Prof. Dr. Arzu Ataseven, Dermatoloji Antalya

From a safety perspective, stem cell therapy—particularly when autologous cells are used—is generally well tolerated and associated with a low risk of systemic adverse effects. However, allogeneic stem cell applications may carry a higher risk of immunologic reactions, making careful patient selection and standardized treatment protocols essential. Furthermore, the source of the cells, processing techniques, and application methods play a critical role in achieving predictable clinical outcomes. Factors such as whether autologous adipose-derived stem cells, stromal vascular fraction (SVF),or cultured mesenchymal stem cells are used can also influence pricing. Since each treatment plan is individualized according to the patient’s clinical needs and regenerative goals, final pricing is generally determined after medical evaluation and consultation. Current scientific literature suggests that stem cell therapy can be an effective method for skin regeneration and tissue repair. However, it should not be considered a “miracle treatment” on its own. Successful outcomes depend on proper patient selection, accurate treatment protocols, and professional clinical application. Although stem cell therapy can be highly effective on its own, it may also demonstrate synergistic effects when combined with supportive aesthetic and regenerative procedures. In clinical practice, stem cell applications are most commonly combined with: